Literature DB >> 17320567

N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model.

Jiaquan Zhu1, Rong Yin, Hongtao Shao, Guohua Dong, Liguo Luo, Hua Jing.   

Abstract

OBJECTIVE: Oxidative stress and systemic inflammation response contribute to acute renal injury post cardiac surgery. We hypothesized that administration of the antioxidant N-acetylcysteine would be beneficial to renal function after cardiopulmonary bypass in a rat model.
METHODS: Male Sprague-Dawley rats were divided into four groups (each n = 6): sham group, cardiopulmonary bypass group, and two N-acetylcysteine-treated cardiopulmonary bypass groups (bolus doses of 200 and 500 mg/kg in cardiopulmonary bypass prime). Blood samples were collected at the beginning of cardiopulmonary bypass, at the cessation of cardiopulmonary bypass, and at 2 and 12 postoperative hours. The kidneys were harvested at 12 postoperative hours.
RESULTS: Serum creatinine and cystatin C continuously increased in all cardiopulmonary bypass groups (P < .05 within groups). Tubular dilatation, tubular necrosis, and vacuole formation were found in epithelial cells in histomorphologic studies of the cardiopulmonary bypass groups, but N-acetylcysteine significantly reversed these effects (P < .05 between groups). Compared with the sham group, the reduced glutathione hormone content and the superoxide dismutase and catalase activities decreased in the cardiopulmonary bypass groups (P < .01). N-acetylcysteine-treated groups had higher levels of these antioxidants than the untreated bypass group (P < .05). Renal malondialdehyde, tumor necrosis factor alpha, and nuclear factor kappaB were notably increased in all cardiopulmonary bypass groups relative to the sham group (P < .01), and N-acetylcysteine attenuated these changes dose dependently.
CONCLUSION: Administration of the antioxidant N-acetylcysteine preserved renal function after cardiopulmonary bypass dose dependently. Furthermore, oxidative stress and systemic inflammation were significantly reduced in the treated animals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320567     DOI: 10.1016/j.jtcvs.2006.09.046

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

Review 1.  Bridging translation for acute kidney injury with better preclinical modeling of human disease.

Authors:  Nataliya I Skrypnyk; Leah J Siskind; Sarah Faubel; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

2.  Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review.

Authors:  Nishith N Patel; Chris A Rogers; Gianni D Angelini; Gavin J Murphy
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

Review 3.  Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials.

Authors:  A Selcuk Adabag; Areef Ishani; Hanna E Bloomfield; Anita K Ngo; Timothy J Wilt
Journal:  Eur Heart J       Date:  2009-03-11       Impact factor: 29.983

4.  The Effect of Acetylcysteine on Renal Function in Experimental Models of Cyclophosphamide-and Ifosfamide-Induced Cystitis.

Authors:  Lukasz Dobrek; Klaudia Nalik-Iwaniak; Kinga Fic; Zbigniew Arent
Journal:  Curr Urol       Date:  2020-10-13

5.  Protective effect of N-acetylcysteine against ethanol-induced gastric ulcer: A pharmacological assessment in mice.

Authors:  Ausama Ayoob Jaccob
Journal:  J Intercult Ethnopharmacol       Date:  2015-03-03

6.  N-acetylcysteine Prevents Kidney and Lung Disturbances in Renal Ischemia/Reperfusion Injury in Rat.

Authors:  Fariba Azarkish; Mehdi Nematbakhsh; Mohammad Fazilati; Ardeshir Talebi; Ali Asghar Pilehvarian; Zahra Pezeshki; Maryam Moeini; Azam Mansouri; Tahereh Safari
Journal:  Int J Prev Med       Date:  2013-10

7.  A novel minimal invasive mouse model of extracorporeal circulation.

Authors:  Shuhua Luo; Menglin Tang; Lei Du; Lina Gong; Jin Xu; Youwen Chen; Yabo Wang; Ke Lin; Qi An
Journal:  Mediators Inflamm       Date:  2015-01-29       Impact factor: 4.711

8.  Cardioprotective effect of ghrelin in cardiopulmonary bypass involves a reduction in inflammatory response.

Authors:  Yukun Cao; Jun Tang; Ting Yang; Heng Ma; Dinghua Yi; Chunhu Gu; Shiqiang Yu
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Multi-factor analysis of failure of renal replacement therapy in acute renal failure developed after cardiac surgery.

Authors:  Pawel Nawrocki; Ireneusz Szwedo; Joanna Tyc; Anna Hawrysz; Kamila Janiak; Romuald Cichoń
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-09-28

Review 10.  Managing the inflammatory response after cardiopulmonary bypass: review of the studies in animal models.

Authors:  Gabriel Romero Liguori; Alexandre Fligelman Kanas; Luiz Felipe Pinho Moreira
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.